Effects of hypothermia for perinatal asphyxia on childhood outcomes
- PMID: 25006720
- DOI: 10.1056/NEJMoa1315788
Effects of hypothermia for perinatal asphyxia on childhood outcomes
Abstract
Background: In the Total Body Hypothermia for Neonatal Encephalopathy Trial (TOBY), newborns with asphyxial encephalopathy who received hypothermic therapy had improved neurologic outcomes at 18 months of age, but it is uncertain whether such therapy results in longer-term neurocognitive benefits.
Methods: We randomly assigned 325 newborns with asphyxial encephalopathy who were born at a gestational age of 36 weeks or more to receive standard care alone (control) or standard care with hypothermia to a rectal temperature of 33 to 34°C for 72 hours within 6 hours after birth. We evaluated the neurocognitive function of these children at 6 to 7 years of age. The primary outcome of this analysis was the frequency of survival with an IQ score of 85 or higher.
Results: A total of 75 of 145 children (52%) in the hypothermia group versus 52 of 132 (39%) in the control group survived with an IQ score of 85 or more (relative risk, 1.31; P=0.04). The proportions of children who died were similar in the hypothermia group and the control group (29% and 30%, respectively). More children in the hypothermia group than in the control group survived without neurologic abnormalities (65 of 145 [45%] vs. 37 of 132 [28%]; relative risk, 1.60; 95% confidence interval, 1.15 to 2.22). Among survivors, children in the hypothermia group, as compared with those in the control group, had significant reductions in the risk of cerebral palsy (21% vs. 36%, P=0.03) and the risk of moderate or severe disability (22% vs. 37%, P=0.03); they also had significantly better motor-function scores. There was no significant between-group difference in parental assessments of children's health status and in results on 10 of 11 psychometric tests.
Conclusions: Moderate hypothermia after perinatal asphyxia resulted in improved neurocognitive outcomes in middle childhood. (Funded by the United Kingdom Medical Research Council and others; TOBY ClinicalTrials.gov number, NCT01092637.).
Comment in
-
[Hypothermia for neonatal asphyxial encephalopathy].Soins Pediatr Pueric. 2014 Sep-Oct;(280):13. Soins Pediatr Pueric. 2014. PMID: 25518246 French. No abstract available.
Similar articles
-
Hypothermia for perinatal asphyxia: trial-based resource use and costs at 6-7 years.Arch Dis Child Fetal Neonatal Ed. 2019 May;104(3):F285-F292. doi: 10.1136/archdischild-2017-314685. Epub 2018 Jul 11. Arch Dis Child Fetal Neonatal Ed. 2019. PMID: 29997167 Free PMC article. Clinical Trial.
-
Hypothermia for perinatal asphyxia: trial-based quality of life at 6-7 years.Arch Dis Child. 2018 Jul;103(7):654-659. doi: 10.1136/archdischild-2017-313733. Epub 2018 Mar 6. Arch Dis Child. 2018. PMID: 29510998 Free PMC article. Clinical Trial.
-
Childhood outcomes after hypothermia for neonatal encephalopathy.N Engl J Med. 2012 May 31;366(22):2085-92. doi: 10.1056/NEJMoa1112066. N Engl J Med. 2012. PMID: 22646631 Free PMC article. Clinical Trial.
-
Cooling for newborns with hypoxic ischaemic encephalopathy.Cochrane Database Syst Rev. 2013 Jan 31;2013(1):CD003311. doi: 10.1002/14651858.CD003311.pub3. Cochrane Database Syst Rev. 2013. PMID: 23440789 Free PMC article. Review.
-
Cooling for newborns with hypoxic ischaemic encephalopathy.Cochrane Database Syst Rev. 2007 Oct 17;(4):CD003311. doi: 10.1002/14651858.CD003311.pub2. Cochrane Database Syst Rev. 2007. Update in: Cochrane Database Syst Rev. 2013 Jan 31;(1):CD003311. doi: 10.1002/14651858.CD003311.pub3 PMID: 17943788 Updated. Review.
Cited by
-
A bibliometric study on clinical research in neonatal encephalopathy.Front Pediatr. 2024 Nov 1;12:1403671. doi: 10.3389/fped.2024.1403671. eCollection 2024. Front Pediatr. 2024. PMID: 39554309 Free PMC article. Review.
-
Hearing loss in newborn infants with hypoxic ischaemic encephalopathy: protocol for a case-control study.BMJ Paediatr Open. 2024 Nov 13;8(1):e002487. doi: 10.1136/bmjpo-2023-002487. BMJ Paediatr Open. 2024. PMID: 39542448 Free PMC article.
-
Dexmedetomidine Improves Long-term Neurological Outcomes by Promoting Oligodendrocyte Genesis and Myelination in Neonatal Rats Following Hypoxic-ischemic Brain Injury.Mol Neurobiol. 2024 Nov 4. doi: 10.1007/s12035-024-04564-z. Online ahead of print. Mol Neurobiol. 2024. PMID: 39496877
-
Individualized Neuroprognostication in Neonates With Hypoxic-Ischemic Encephalopathy Treated With Hypothermia.Neurol Clin Pract. 2025 Feb;15(1):e200370. doi: 10.1212/CPJ.0000000000200370. Epub 2024 Oct 8. Neurol Clin Pract. 2025. PMID: 39399559
-
Exploring the potential cost-effectiveness of a new computerised decision support tool for identifying fetal compromise during monitored term labours: an early health economic model.Cost Eff Resour Alloc. 2024 Oct 7;22(1):72. doi: 10.1186/s12962-024-00580-x. Cost Eff Resour Alloc. 2024. PMID: 39375735 Free PMC article.
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources